|
|||||
|
|
Complement-Based Therapy in the Management of Antibody-Mediated Rejection |
|
| Affiliation: | 1. Division of Transplant Surgery, Department of Surgery, James D. Eason Transplant Institute, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, TN;2. Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD |
| Abstract: | |
| Keywords: | Transplant Rejection Complement Eculizumab C1 esterase inhibitor |
| 本文献已被 ScienceDirect 等数据库收录！ | |